Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patients
Not Applicable
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000026869
- Lead Sponsor
- Shiga University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
Not applicable
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence-free survival (RFS)
- Secondary Outcome Measures
Name Time Method 1) Overall survival (OS) 2) To evaluate the correlation between Galectin-3 expression in non-small cell lung cancer tissues and clinicopathological features 3) To investigate the correlation between Galectin-3 expression in tissue and serum from non-small cell lung cancer patients